Search for: "Foley & Lardner, LLP."
Results 81 - 100
of 311
Sorted by Relevance
|
Sort by Date
9 Jan 2011, 8:59 pm
January 11, 2011 - Gene Patenting -- Defining a Potentially Pivotal Moment in Biotech (Foley & Lardner LLP) - 12:00 to 1:00 pm (EST) January 12, 2011 - New USPTO Guidelines and the Obviousness Standard for Patents (Strafford) - 1:00 - 2:30 PM (EST) January 21, 2011 - Patents, Innovation and Job Creation: A Virtuous Circle (Innovation Alliance) - Washington, DC January 25, 2011 - Understanding Obviousness in a Post-KSR World: Practical Applications for Compliance with… [read post]
30 Jan 2021, 8:46 pm
Houston of Foley & Lardner LLP, and Shaun Snader of United Therapeutics will discuss 2020's major developments at the Patent Trial and Appeal Board (PTAB) and how they may impact patent litigation practice going forward before the PTAB and beyond. [read post]
26 Mar 2013, 12:00 am
During our recently concluded thought leader interview series, I had intended to line up at least one more interview – with Adam Losey, president and editor-in-chief of IT-Lex.org, a technology law not-for-profit educational and literary organization and an attorney at Foley & Lardner LLP. [read post]
21 May 2016, 8:41 pm
Patent and Trademark Office, Courtenay Brinckerhoff of Foley & Lardner, and Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will probe deeply into the new examples published by the USPTO this month that show how claims for life science inventions should be examined by the agency for subject-matter patent eligibility. [read post]
29 Mar 2013, 9:55 pm
A panel consisting of Jason Mudd of Erise IP, Matthew Smith of Foley & Lardner LLP, and Jeanne Suchodolski of Intellectual Ventures will analyze the Patent Trial and Appeals Board (PTAB) decisions since inter partes review (IPR) proceedings became available on September 16, 2012, and rely on their own experience to discuss: • How to get an IPR petition accepted? [read post]
25 Mar 2013, 12:00 am
During our recently concluded thought leader interview series, I had intended to line up at least one more interview – with Adam Losey, president and editor-in-chief of IT-Lex.org, a technology law not-for-profit educational and literary organization and an attorney at Foley & Lardner LLP. [read post]
17 Sep 2008, 4:54 am
Noonan -- Harold Wegner, dean of patent law cognoscenti and a partner at Foley & Lardner LLP in Washington, DC, regaled the audience at ACI's Biotech Patent Law conference on Monday with a talk on "Key Biotech Cases to Watch and How They May Impact Your Practice. [read post]
14 Jun 2013, 9:15 pm
Foley & Lardner will be offering a web conference entitled "The Supreme Court Decision(s) in Myriad: What Did the Justices Say? [read post]
27 Feb 2015, 7:23 pm
Courtenay Brinckerhoff of Foley & Lardner; Matthew Dowd of Wiley Rein, LLP; and Mary Till, USPTO Office of Patent Legal Administration will cover evidentiary declarations under the First Inventor to File (FITF) system, including declarations relating to the 1-year grace period under the new section 102(b), explain Rule 132 declarations and other evidence to overcome obviousness rejections, and demonstrate how to avoid common pitfalls that can... [read post]
2 May 2020, 8:09 pm
Ute Kilger of Boehmert & Boehmert will moderate a panel consisting of Robert DeBerardine of Johnson & Johnson, David Rosen of Foley & Lardner LLP, Corey Salsberg of Novartis, and Hans Sauer of the Biotechnology Innovation Organization (BIO). [read post]
5 Aug 2018, 9:52 pm
Courtenay Brinckerhoff of Foley & Lardner LLP, Charles Chesney of Qualcomm Inc., and Roland McAndrews of Bookoff McAndrews PLLC will discuss potential pitfalls associated with U.S. provisional or CIP patent applications. [read post]
29 Apr 2024, 11:54 am
The post DOL Increases Compensation Threshold for Exempt Employees appeared first on Foley & Lardner LLP. [read post]
15 Apr 2024, 11:52 am
The post New Florida Law Highlights Renewed Interest in Child Labor appeared first on Foley & Lardner LLP. [read post]
19 Mar 2024, 7:01 am
The post Motion to Strike Damages Expert Leads to Denial of Class Certification appeared first on Foley & Lardner LLP. [read post]
6 May 2024, 9:38 am
The post Update: Supreme Court Revises Title VII’s Decades-Old “Adverse Employment Action” Standard for Discriminatory Transfers appeared first on Foley & Lardner LLP. [read post]
18 Feb 2022, 6:34 am
Protostorm, Inc. v Foley & Lardner LLP, 2022 NY Slip Op 01107, Decided on February 17, 2022, Appellate Division, First Department is a short decision concerning a small act with big consequences. [read post]
2 Apr 2008, 3:27 am
Foley & Lardner, Harry C. [read post]
26 Aug 2012, 8:51 pm
(Foley & Lardner) - 3:00 pm (Eastern) August 30, 2012 - The Written Description Requirement: Are Antibodies Chemicals, Proteins, or Exceptions? [read post]
18 Jan 2024, 5:14 pm
Sanofi appeared first on Foley & Lardner LLP. [read post]
17 Nov 2023, 11:24 am
The post Revisiting FDA’s Original Guidance on Orange Book Listability in Light of Heightened FTC Scrutiny appeared first on Foley & Lardner LLP. [read post]
